MedPath

BP CONSULTING, INC.

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:11

Trial Phases

1 Phases

Phase 4:11

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 4
11 (100.0%)

Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

Phase 4
Completed
Conditions
Intraocular Pressure
Interventions
First Posted Date
2009-01-26
Last Posted Date
2009-06-10
Lead Sponsor
Bp Consulting, Inc
Target Recruit Count
25
Registration Number
NCT00828477
Locations
🇺🇸

Coburn-Kleinfeldt Eye Clinic, 3340 6 mile Rd Livonia, Michigan, United States

Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.

Phase 4
Completed
Conditions
Diabetic Macular Edema
Interventions
Drug: Bromefenac
Drug: Blink
First Posted Date
2008-09-25
Last Posted Date
2009-09-04
Lead Sponsor
Bp Consulting, Inc
Target Recruit Count
50
Registration Number
NCT00758628
Locations
🇺🇸

Retina Eye Associates of New York, 140 East 80th street New York, NY 10075, New York, United States

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

First Posted Date
2008-09-25
Last Posted Date
2012-03-15
Lead Sponsor
Bp Consulting, Inc
Target Recruit Count
49
Registration Number
NCT00758199
Locations
🇺🇸

Altos Eye Physicians, Los Altos, California, United States

Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care

Phase 4
Completed
Conditions
Cataracts
Interventions
Drug: Xibrom, and Optive
First Posted Date
2008-06-17
Last Posted Date
2009-06-10
Lead Sponsor
Bp Consulting, Inc
Target Recruit Count
200
Registration Number
NCT00698724
Locations
🇺🇸

St. Luke's Cataract and Laser institute, Tarpon Springs, Florida, United States

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.